{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:14:18Z","timestamp":1790486058176,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,9,14]],"date-time":"2012-09-14T00:00:00Z","timestamp":1347580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00259-012-2232-7","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T09:56:04Z","timestamp":1347530164000},"page":"1937-1948","source":"Crossref","is-referenced-by-count":52,"title":["Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study"],"prefix":"10.1007","volume":"39","author":[{"given":"Daniela","family":"Di Giuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Camardese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Rita","family":"Bentivoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Cocciolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Guidubaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorella","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Janiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,14]]},"reference":[{"issue":"5","key":"2232_CR1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/mds.21376","volume":"22","author":"KM Miller","year":"2007","unstructured":"Miller KM, Okun MS, Fernandez HF, Jacobson CE, Rodriguez RL, Bowers D. Depression symptoms in movement disorders: comparing Parkinson\u2019s disease, dystonia, and essential tremor. Mov Disord. 2007;22(5):666\u201372.","journal-title":"Mov Disord"},{"issue":"5","key":"2232_CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1468-1331.2004.00781.x","volume":"11","author":"A Nuti","year":"2004","unstructured":"Nuti A, Ceravolo R, Piccinni A, Dell\u2019Agnello G, Bellini G, Gambaccini G, et al. Psychiatric comorbidity in a population of Parkinson\u2019s disease patients. Eur J Neurol. 2004;11(5):315\u201320.","journal-title":"Eur J Neurol"},{"issue":"10","key":"2232_CR3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00019442-200510000-00003","volume":"13","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Stern MB. Psychiatric complications in Parkinson disease. Am J Geriatr Psychiatr. 2005;13(10):844\u201351.","journal-title":"Am J Geriatr Psychiatr"},{"issue":"7","key":"2232_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mds.22833","volume":"25","author":"NN Dissanayaka","year":"2010","unstructured":"Dissanayaka NN, Sellbach A, Matheson S, O\u2019Sullivan JD, Silburn PA, Byrne GJ, et al. Anxiety disorders in Parkinson\u2019s disease: prevalence and risk factors. Mov Disord. 2010;25(7):838\u201345.","journal-title":"Mov Disord"},{"issue":"6","key":"2232_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.parkreldis.2005.04.007","volume":"11","author":"EK Tan","year":"2005","unstructured":"Tan EK, Fook-Chong S, Lum SY, Gabriel C, Koh KK, Prakash KM, et al. Non-motor manifestations in essential tremor: use of a validated instrument to evaluate a wide spectrum of symptoms. Parkinsonism Relat Disord. 2005;11(6):375\u201380.","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"2232_CR6","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/jnnp.2004.037176","volume":"75","author":"A Chatterjee","year":"2004","unstructured":"Chatterjee A, Jurewicz EC, Applegate LM, Louis ED. Personality in essential tremor: further evidence of non-motor manifestations of the disease. J Neurol Neurosurg Psychiatry. 2004;75(7):958\u201361.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"2232_CR7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2008.170191","volume":"80","author":"R Lencer","year":"2009","unstructured":"Lencer R, Steinlechner S, Stahlberg J, Rehling H, Orth M, Baeumer T, et al. Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatr. 2009;80(10):1176\u20139.","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"4","key":"2232_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mds.22983","volume":"25","author":"G Fabbrini","year":"2010","unstructured":"Fabbrini G, Berardelli I, Moretti G, Pasquini M, Bloise M, Colosimo C, et al. Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord. 2010;25(4):459\u201365.","journal-title":"Mov Disord"},{"issue":"7","key":"2232_CR9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mds.23709","volume":"26","author":"DJ Kuyper","year":"2011","unstructured":"Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM. Nonmotor manifestations of dystonia: a systematic review. Mov Disord. 2011;26(7):1206\u201317. doi: 10.1002\/mds.23709 .","journal-title":"Mov Disord"},{"issue":"2","key":"2232_CR10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0361-9230(83)90183-1","volume":"11","author":"D Flinn","year":"1983","unstructured":"Flinn D, Bazzell W. Psychiatric aspects of abnormal movement disorders. Brain Res Bull. 1983;11(2):153\u201361.","journal-title":"Brain Res Bull"},{"issue":"Suppl 2","key":"2232_CR11","doi-asserted-by":"crossref","first-page":"II3","DOI":"10.1007\/PL00007758","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak H, Braak E. Pathoanatomy of Parkinson\u2019s disease. J Neurol. 2000;247 Suppl 2:II3\u201310.","journal-title":"J Neurol"},{"issue":"5","key":"2232_CR12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.34.5.642","volume":"34","author":"R Mayeux","year":"1984","unstructured":"Mayeux R, Stern Y, Cote L, Williams JB. Altered serotonin metabolism in depressed patients with Parkinson\u2019s disease. Neurology. 1984;34(5):642\u20136.","journal-title":"Neurology"},{"issue":"Pt 6","key":"2232_CR13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain. 2005;128(Pt 6):1314\u201322.","journal-title":"Brain"},{"issue":"1","key":"2232_CR14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2009.06.009","volume":"204","author":"S Nikolaus","year":"2009","unstructured":"Nikolaus S, Antke C, Muller HW. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. Behav Brain Res. 2009;204(1):32\u201366.","journal-title":"Behav Brain Res"},{"issue":"4","key":"2232_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pnpbp.2010.02.028","volume":"34","author":"MC Freitas-Ferrari","year":"2010","unstructured":"Freitas-Ferrari MC, Hallak JE, Trzesniak C, Filho AS, Machado-de-Sousa JP, Chagas MH, et al. Neuroimaging in social anxiety disorder: a systematic review of the literature. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(4):565\u201380.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"2232_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10072-003-0103-5","volume":"24","author":"A Antonini","year":"2003","unstructured":"Antonini A, Benti R, De Notaris R, Tesei S, Zecchinelli A, Sacilotto G, et al. 123I-Ioflupane\/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci. 2003;24(3):149\u201350.","journal-title":"Neurol Sci"},{"issue":"2","key":"2232_CR17","first-page":"227","volume":"46","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson\u2019s disease. J Nucl Med. 2005;46(2):227\u201332.","journal-title":"J Nucl Med"},{"issue":"11","key":"2232_CR18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/mds.22158","volume":"23","author":"I Rektorova","year":"2008","unstructured":"Rektorova I, Srovnalova H, Kubikova R, Prasek J. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson\u2019s disease. Mov Disord. 2008;23(11):1580\u20137.","journal-title":"Mov Disord"},{"issue":"2","key":"2232_CR19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/appi.ajp.158.2.314","volume":"158","author":"M Martinot","year":"2001","unstructured":"Martinot M, Bragulat V, Artiges E, Dolle F, Hinnen F, Jouvent R, et al. Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry. 2001;158(2):314\u20136.","journal-title":"Am J Psychiatry"},{"issue":"2\u20133","key":"2232_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pscychresns.2006.03.001","volume":"147","author":"M Sarchiapone","year":"2006","unstructured":"Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, et al. Dopamine transporter binding in depressed patients with anhedonia. Psychiatr Res. 2006;147(2\u20133):243\u20138.","journal-title":"Psychiatr Res"},{"issue":"10","key":"2232_CR21","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1176\/appi.ajp.160.10.1836","volume":"160","author":"DJ Brunswick","year":"2003","unstructured":"Brunswick DJ, Amsterdam JD, Mozley PD, Newberg A. Greater availability of brain dopamine transporters in major depression shown by [99mTc]TRODAT-1 SPECT imaging. Am J Psychiatry. 2003;160(10):1836\u201341.","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"2232_CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2005.08.016","volume":"89","author":"M Argyelan","year":"2005","unstructured":"Argyelan M, Szabo Z, Kanyo B, Tanacs A, Kovacs Z, Janka Z, et al. Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord. 2005;89(1\u20133):115\u201323.","journal-title":"J Affect Disord"},{"issue":"3","key":"2232_CR23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pscychresns.2007.08.008","volume":"162","author":"YK Yang","year":"2008","unstructured":"Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT, et al. Greater availability of dopamine transporters in patients with major depression \u2013 a dual-isotope SPECT study. Psychiatr Res. 2008;162(3):230\u20135.","journal-title":"Psychiatr Res"},{"issue":"1","key":"2232_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1176\/appi.neuropsych.23.1.63","volume":"23","author":"H Wu","year":"2011","unstructured":"Wu H, Lou C, Huang Z, Shi G. SPECT imaging of dopamine transporters with 99mTc-TRODAT-1 in major depression and Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci. 2011;23(1):63\u20137.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"10","key":"2232_CR25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1468-1331.2007.01923.x","volume":"14","author":"ED Louis","year":"2007","unstructured":"Louis ED, Benito-Leon J, Bermejo-Pareja F. Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol. 2007;14(10):1138\u201346.","journal-title":"Eur J Neurol"},{"issue":"1","key":"2232_CR26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jocn.2010.05.021","volume":"18","author":"ZW Li","year":"2011","unstructured":"Li ZW, Xie MJ, Tian DS, Li JJ, Zhang JP, Jiao L, et al. Characteristics of depressive symptoms in essential tremor. J Clin Neurosci. 2011;18(1):52\u20136.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"2232_CR27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0404.2011.01573.x","volume":"125","author":"V Chandran","year":"2012","unstructured":"Chandran V, Pal PK, Reddy JY, Thennarasu K, Yadav R, Shivashankar N. Non-motor features in essential tremor. Acta Neurol Scand. 2012;125(5):332\u20137.","journal-title":"Acta Neurol Scand"},{"key":"2232_CR28","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision. DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000."},{"issue":"1","key":"2232_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33\u20139.","journal-title":"Arch Neurol"},{"key":"2232_CR30","volume-title":"Recent developments in Parkinson\u2019s disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton R, Committee MotUD. The Unified Parkinson\u2019s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent Developments in Parkinson\u2019s Disease. Vol. 2. Florham Park, NJ: Macmillan Healthcare Information; 1987. p. 153\u2013163.p. 293\u2013304."},{"issue":"Suppl 3","key":"2232_CR31","first-page":"2","volume":"13","author":"G Deuschl","year":"1998","unstructured":"Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13 Suppl 3:2\u201323.","journal-title":"Mov Disord"},{"issue":"5","key":"2232_CR32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1468-1331.2006.01537.x","volume":"13","author":"A Albanese","year":"2006","unstructured":"Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Filippini G, Gasser T, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS\/MDS-ES Task Force. Eur J Neurol. 2006;13(5):433\u201344.","journal-title":"Eur J Neurol"},{"issue":"7","key":"2232_CR33","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/WNL.35.7.1066","volume":"35","author":"RE Burke","year":"1985","unstructured":"Burke RE, Fahn S. Serum trihexyphenidyl levels in the treatment of torsion dystonia. Neurology. 1985;35(7):1066\u20139.","journal-title":"Neurology"},{"issue":"2","key":"2232_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00259-009-1267-x","volume":"37","author":"J Darcourt","year":"2010","unstructured":"Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37(2):443\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2232_CR35","volume-title":"Cranial neuroimaging and clinical neuroanatomy","author":"H Kretschmann","year":"1992","unstructured":"Kretschmann H, Weinrich W. Cranial neuroimaging and clinical neuroanatomy. Stuttgart: Thieme; 1992."},{"issue":"1","key":"2232_CR36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MNM.0b013e328013dc9d","volume":"28","author":"A Newberg","year":"2007","unstructured":"Newberg A, Amsterdam J, Shults J. Dopamine transporter density may be associated with the depressed affect in healthy subjects. Nucl Med Commun. 2007;28(1):3\u20136.","journal-title":"Nucl Med Commun"},{"key":"2232_CR37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2232_CR38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.167.4.522","volume":"167","author":"JD Mellers","year":"1995","unstructured":"Mellers JD, Quinn NP, Ron MA. Psychotic and depressive symptoms in Parkinson\u2019s disease. A study of the growth hormone response to apomorphine. Br J Psychiatry. 1995;167(4):522\u20136.","journal-title":"Br J Psychiatry"},{"issue":"7","key":"2232_CR39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L","volume":"15","author":"AF Leentjens","year":"2000","unstructured":"Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson\u2019s disease. Int J Geriatr Psychiatr. 2000;15(7):644\u20139.","journal-title":"Int J Geriatr Psychiatr"},{"issue":"1","key":"2232_CR40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50\u20135.","journal-title":"Br J Med Psychol"},{"issue":"14","key":"2232_CR41","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/mds.22233","volume":"23","author":"AF Leentjens","year":"2008","unstructured":"Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Anxiety rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2008;23(14):2015\u201325.","journal-title":"Mov Disord"},{"issue":"11","key":"2232_CR42","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.clinthera.2006.11.007","volume":"28","author":"RS McIntyre","year":"2006","unstructured":"McIntyre RS, Fallu A, Konarski JZ. Measurable outcomes in psychiatric disorders: remission as a marker of wellness. Clin Ther. 2006;28(11):1882\u201391.","journal-title":"Clin Ther"},{"issue":"1","key":"2232_CR43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","volume":"167","author":"RP Snaith","year":"1995","unstructured":"Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale. Br J Psychiatry. 1995;167(1):99\u2013103.","journal-title":"Br J Psychiatry"},{"issue":"14","key":"2232_CR44","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/mds.22229","volume":"23","author":"AF Leentjens","year":"2008","unstructured":"Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Apathy and anhedonia rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2008;23(14):2004\u201314.","journal-title":"Mov Disord"},{"issue":"2","key":"2232_CR45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1176\/appi.neuropsych.17.2.214","volume":"17","author":"MR Lemke","year":"2005","unstructured":"Lemke MR, Brecht HM, Koester J, Kraus PH, Reichmann H. Anhedonia, depression, and motor functioning in Parkinson\u2019s disease during treatment with pramipexole. J Neuropsychiatry Clin Neurosci. 2005;17(2):214\u201320.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"2232_CR46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1176\/appi.neuropsych.18.3.397","volume":"18","author":"K Witt","year":"2006","unstructured":"Witt K, Daniels C, Herzog J, Lorenz D, Volkmann J, Reiff J, et al. Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci. 2006;18(3):397\u2013401.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"2232_CR47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.yco.0000218601.17722.5b","volume":"19","author":"H Rickards","year":"2006","unstructured":"Rickards H. Depression in neurological disorders: an update. Curr Opin Psychiatr. 2006;19(3):294\u20138.","journal-title":"Curr Opin Psychiatr"},{"issue":"1","key":"2232_CR48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jnnp.2008.157370","volume":"81","author":"G Kagi","year":"2010","unstructured":"Kagi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81(1):5\u201312.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2232_CR49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00406-004-0520-3","volume":"254","author":"E Maron","year":"2004","unstructured":"Maron E, Kuikka JT, Ulst K, Tiihonen J, Vasar V, Shlik J. SPECT imaging of serotonin transporter binding in patients with generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci. 2004;254(6):392\u20136.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"5","key":"2232_CR50","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2967\/jnumed.107.045518","volume":"49","author":"NJ Wee van der","year":"2008","unstructured":"van der Wee NJ, van Veen JF, Stevens H, van Vliet IM, van Rijk PP, Westenberg HG. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med. 2008;49(5):757\u201363.","journal-title":"J Nucl Med"},{"issue":"5","key":"2232_CR51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/da.20543","volume":"26","author":"FR Schneier","year":"2009","unstructured":"Schneier FR, Abi-Dargham A, Martinez D, Slifstein M, Hwang DR, Liebowitz MR, et al. Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder. Depress Anxiety. 2009;26(5):411\u20138.","journal-title":"Depress Anxiety"},{"issue":"4","key":"2232_CR52","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","volume":"15","author":"M Shiba","year":"2000","unstructured":"Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, et al. Anxiety disorders and depressive disorders preceding Parkinson\u2019s disease: a case-control study. Mov Disord. 2000;15(4):669\u201377.","journal-title":"Mov Disord"},{"issue":"6","key":"2232_CR53","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.48.6.1578","volume":"48","author":"M Guttman","year":"1997","unstructured":"Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, et al. [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson\u2019s disease: implications for the symptomatic threshold. Neurology. 1997;48(6):1578\u201383.","journal-title":"Neurology"},{"issue":"5","key":"2232_CR54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00415-006-0067-5","volume":"253","author":"P Barone","year":"2006","unstructured":"Barone P, Scarzella L, Marconi R, Antonini A, Morgante L, Bracco F, et al. Pramipexole versus sertraline in the treatment of depression in Parkinson\u2019s disease: a national multicenter parallel-group randomized study. J Neurol. 2006;253(5):601\u20137.","journal-title":"J Neurol"},{"issue":"14","key":"2232_CR55","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.wnl.0000258660.74391.c1","volume":"68","author":"R Pahwa","year":"2007","unstructured":"Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, et al. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology. 2007;68(14):1108\u201315.","journal-title":"Neurology"},{"issue":"10","key":"2232_CR56","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/j.1460-9568.2007.05580.x","volume":"25","author":"J Koerts","year":"2007","unstructured":"Koerts J, Leenders KL, Koning M, Portman AT, van Beilen M. Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson\u2019s disease. Eur J Neurosci. 2007;25(10):3132\u20136.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"2232_CR57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-008-0979-7","volume":"36","author":"S Hesse","year":"2009","unstructured":"Hesse S, Meyer PM, Strecker K, Barthel H, Wegner F, Oehlwein C, et al. Monoamine transporter availability in Parkinson\u2019s disease patients with or without depression. Eur J Nucl Med Mol Imaging. 2009;36(3):428\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"23","key":"2232_CR58","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1073\/pnas.231313198","volume":"98","author":"V Kaasinen","year":"2001","unstructured":"Kaasinen V, Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P, et al. Personality traits and brain dopaminergic function in Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2001;98(23):13272\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"2232_CR59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2011.06.056","volume":"310","author":"TS Moriyama","year":"2011","unstructured":"Moriyama TS, Felicio AC, Chagas MH, Tardelli VS, Ferraz HB, Tumas V, et al. Increased dopamine transporter density in Parkinson\u2019s disease patients with social anxiety disorder. J Neurol Sci. 2011;310(1\u20132):53\u20137.","journal-title":"J Neurol Sci"},{"issue":"2","key":"2232_CR60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mds.22760","volume":"25","author":"L Negre-Pages","year":"2010","unstructured":"Negre-Pages L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lepine JP, et al. Anxious and depressive symptoms in Parkinson\u2019s disease: the French cross-sectional DoPaMiP study. Mov Disord. 2010;25(2):157\u201366.","journal-title":"Mov Disord"},{"issue":"6","key":"2232_CR61","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(10)70090-9","volume":"9","author":"ED Louis","year":"2010","unstructured":"Louis ED. Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem enquiry. Lancet Neurol. 2010;9(6):613\u201322.","journal-title":"Lancet Neurol"},{"issue":"11","key":"2232_CR62","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nn1544","volume":"8","author":"E Hoshi","year":"2005","unstructured":"Hoshi E, Tremblay L, Feger J, Carras PL, Strick PL. The cerebellum communicates with the basal ganglia. Nat Neurosci. 2005;8(11):1491\u20133.","journal-title":"Nat Neurosci"},{"key":"2232_CR63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.0065-1591.2000.acp29-04.x","volume":"406","author":"P Boyer","year":"2000","unstructured":"Boyer P. Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl. 2000;406:24\u20139.","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"4","key":"2232_CR64","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3758\/CABN.8.4.375","volume":"8","author":"SB Floresco","year":"2008","unstructured":"Floresco SB, St Onge JR, Ghods-Sharifi S, Winstanley CA. Cortico-limbic-striatal circuits subserving different forms of cost-benefit decision making. Cognit Affect Behav Neurosci. 2008;8(4):375\u201389.","journal-title":"Cognit Affect Behav Neurosci"},{"issue":"4","key":"2232_CR65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MNM.0b013e3282f4d307","volume":"29","author":"IU Isaias","year":"2008","unstructured":"Isaias IU, Canesi M, Benti R, Gerundini P, Cilia R, Pezzoli G, et al. Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl Med Commun. 2008;29(4):349\u201353.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"2232_CR66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.parkreldis.2004.03.004","volume":"10","author":"M Schwartz","year":"2004","unstructured":"Schwartz M, Groshar D, Inzelberg R, Hocherman S. Dopamine-transporter imaging and visuo-motor testing in essential tremor, practical possibilities for detection of early stage Parkinson\u2019s disease. Parkinsonism Relat Disord. 2004;10(6):385\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2232_CR67","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1523\/JNEUROSCI.17-02-00843.1997","volume":"17","author":"JS Perlmutter","year":"1997","unstructured":"Perlmutter JS, Stambuk MK, Markham J, Black KJ, McGee-Minnich L, Jankovic J, et al. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci. 1997;17(2):843\u201350.","journal-title":"J Neurosci"},{"issue":"24","key":"2232_CR68","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/WNL.0b013e3181aa538f","volume":"72","author":"M Carbon","year":"2009","unstructured":"Carbon M, Niethammer M, Peng S, Raymond D, Dhawan V, Chaly T, et al. Abnormal striatal and thalamic dopamine neurotransmission: genotype-related features of dystonia. Neurology. 2009;72(24):2097\u2013103.","journal-title":"Neurology"},{"issue":"3","key":"2232_CR69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.biopsych.2006.05.043","volume":"61","author":"J Sareen","year":"2007","unstructured":"Sareen J, Campbell DW, Leslie WD, Malisza KL, Stein MB, Paulus MP, et al. Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry. 2007;61(3):396\u2013404.","journal-title":"Biol Psychiatry"},{"issue":"11","key":"2232_CR70","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/hbm.20801","volume":"30","author":"PC Koolschijn","year":"2009","unstructured":"Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp. 2009;30(11):3719\u201335.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"2232_CR71","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","volume":"64","author":"BW Dunlop","year":"2007","unstructured":"Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry. 2007;64(3):327\u201337.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2232_CR72","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1017\/S0033291700022261","volume":"21","author":"S Fleminger","year":"1991","unstructured":"Fleminger S. Left-sided Parkinson\u2019s disease is associated with greater anxiety and depression. Psychol Med. 1991;21(3):629\u201338.","journal-title":"Psychol Med"},{"issue":"1","key":"2232_CR73","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/mds.22896","volume":"25","author":"E Cubo","year":"2010","unstructured":"Cubo E, Martin PM, Martin-Gonzalez JA, Rodriguez-Blazquez C, Kulisevsky J. Motor laterality asymmetry and nonmotor symptoms in Parkinson\u2019s disease. Mov Disord. 2010;25(1):70\u20135.","journal-title":"Mov Disord"},{"issue":"2","key":"2232_CR74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neures.2010.06.013","volume":"68","author":"D Hecht","year":"2010","unstructured":"Hecht D. Depression and the hyperactive right-hemisphere. Neurosci Res. 2010;68(2):77\u201387.","journal-title":"Neurosci Res"},{"issue":"1\u20133","key":"2232_CR75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jad.2009.04.021","volume":"120","author":"V Lorenzetti","year":"2010","unstructured":"Lorenzetti V, Allen NB, Whittle S, Yucel M. Amygdala volumes in a sample of current depressed and remitted depressed patients and healthy controls. J Affect Disord. 2010;120(1\u20133):112\u20139.","journal-title":"J Affect Disord"},{"issue":"2","key":"2232_CR76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/jnp.7.2.176","volume":"7","author":"MA Menza","year":"1995","unstructured":"Menza MA, Mark MH, Burn DJ, Brooks DJ. Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci. 1995;7(2):176\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"Pt 4","key":"2232_CR77","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","volume":"117","author":"KP Bhatia","year":"1994","unstructured":"Bhatia KP, Marsden CD. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117(Pt 4):859\u201376.","journal-title":"Brain"},{"key":"2232_CR78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0140525X00047488","volume":"10","author":"NR Swerdlow","year":"1987","unstructured":"Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav Brain Sci. 1987;10:197\u2013245.","journal-title":"Behav Brain Sci"},{"issue":"5","key":"2232_CR79","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archpsyc.1985.01790280019002","volume":"42","author":"LR Baxter Jr","year":"1985","unstructured":"Baxter Jr LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, et al. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry. 1985;42(5):441\u20137.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"2232_CR80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-0327(86)90036-4","volume":"10","author":"MS Buchsbaum","year":"1986","unstructured":"Buchsbaum MS, Wu J, DeLisi LE, Holcomb H, Kessler R, Johnson J, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord. 1986;10(2):137\u201352.","journal-title":"J Affect Disord"},{"key":"2232_CR81","doi-asserted-by":"crossref","unstructured":"Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998;(35):26\u201337.","DOI":"10.1192\/S0007125000297870"},{"issue":"1","key":"2232_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145701002681","volume":"5","author":"ES Hansen","year":"2002","unstructured":"Hansen ES, Hasselbalch S, Law I, Bolwig TG. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. Int J Neuropsychopharmacol. 2002;5(1):1\u201310.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"2232_CR83","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archpsyc.62.8.922","volume":"62","author":"OA Heuvel van den","year":"2005","unstructured":"van den Heuvel OA, Veltman DJ, Groenewegen HJ, Witter MP, Merkelbach J, Cath DC, et al. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry. 2005;62(8):922\u201333.","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"2232_CR84","first-page":"359","volume":"48","author":"J Booij","year":"2007","unstructured":"Booij J, de Jong J, de Bruin K, Knol R, de Win MM, van Eck-Smit BL. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. J Nucl Med. 2007;48(3):359\u201366.","journal-title":"J Nucl Med"},{"issue":"2","key":"2232_CR85","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0306-4522(88)90282-5","volume":"27","author":"R Cortes","year":"1988","unstructured":"Cortes R, Soriano E, Pazos A, Probst A, Palacios JM. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine. Neuroscience. 1988;27(2):473\u201396.","journal-title":"Neuroscience"},{"issue":"12","key":"2232_CR86","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2967\/jnumed.110.078337","volume":"51","author":"M Ziebell","year":"2010","unstructured":"Ziebell M, Holm-Hansen S, Thomsen G, Wagner A, Jensen P, Pinborg LH, et al. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I. J Nucl Med. 2010;51(12):1885\u201391.","journal-title":"J Nucl Med"},{"issue":"12","key":"2232_CR87","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/mds.22212","volume":"23","author":"I Boileau","year":"2008","unstructured":"Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, et al. Elevated serotonin transporter binding in depressed patients with Parkinson\u2019s disease: a preliminary PET study with [11C]DASB. Mov Disord. 2008;23(12):1776\u201380.","journal-title":"Mov Disord"},{"key":"2232_CR88","first-page":"27","volume":"56","author":"K Tatsch","year":"2012","unstructured":"Tatsch K, Poepperl G. Quantitative approach to dopaminergic brain imaging. Q J Nucl Med Mol Imaging. 2012;56:27\u201338.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"3\u20134","key":"2232_CR89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000106476","volume":"55","author":"JD Amsterdam","year":"2007","unstructured":"Amsterdam JD, Newberg AB. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology. 2007;55(3\u20134):167\u201370.","journal-title":"Neuropsychobiology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-012-2232-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-012-2232-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-012-2232-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T17:00:36Z","timestamp":1562173236000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-012-2232-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,14]]},"references-count":89,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1007\/s00259-012-2232-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,14]]}}}